Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhei Nishiguchi

Showing results (251-260 of 303) with videos related to

Pageof 31
Sort By:
Gastroenterology Research and Practice|April 3, 2014
An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive PatientsHirayuki Enomoto, Nobuhiro Aizawa, Hideji Nakamura, et al.
Gastroenterology Research and Practice|February 5, 2016
Corrigendum to "An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients"Hirayuki Enomoto, Nobuhiro Aizawa, Hideji Nakamura, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 20, 2017
Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosisHiroki Nishikawa, Hirayuki Enomoto, Akio Ishii, et al.
Nutrients|June 13, 2017
Comparison of Prognostic Impact between the Child-Pugh Score and Skeletal Muscle Mass for Patients with Liver CirrhosisHiroki Nishikawa, Hirayuki Enomoto, Akio Ishii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 14, 2017
Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trialKazuyuki Suzuki, Ryujin Endo, Yasuhiro Takikawa, et al.
BMJ Open Gastroenterology|March 13, 2018
Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trialKazunori Yoh, Hiroki Nishikawa, Hirayuki Enomoto, et al.
BMJ Open Gastroenterology|January 16, 2018
Clinical influence of exercise therapy on sarcopenia in patients with chronic pancreatitis: a study protocol for a randomised controlled trialKazunori Yoh, Hiroki Nishikawa, Hirayuki Enomoto, et al.
Gastroenterology Research and Practice|April 11, 2015
A new metabolism-related index correlates with the degree of liver fibrosis in hepatitis C virus-positive patientsHirayuki Enomoto, Nobuhiro Aizawa, Hideji Nakamura, et al.
Journal of Gastroenterology|April 1, 2021
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitisJun Itakura, Masayuki Kurosaki, Hiroko Setoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 25, 2010
[A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of UFT-E]Hirayuki Enomoto, Akio Ishii, Hiroyasu Imanishi, et al.
Pageof 31

Showing results (251-260 of 303) with videos related to

Sort By:
Pageof 31
Gastroenterology Research and Practice|April 3, 2014
An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive PatientsHirayuki Enomoto, Nobuhiro Aizawa, Hideji Nakamura, et al.
Gastroenterology Research and Practice|February 5, 2016
Corrigendum to "An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients"Hirayuki Enomoto, Nobuhiro Aizawa, Hideji Nakamura, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 20, 2017
Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosisHiroki Nishikawa, Hirayuki Enomoto, Akio Ishii, et al.
Nutrients|June 13, 2017
Comparison of Prognostic Impact between the Child-Pugh Score and Skeletal Muscle Mass for Patients with Liver CirrhosisHiroki Nishikawa, Hirayuki Enomoto, Akio Ishii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 14, 2017
Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trialKazuyuki Suzuki, Ryujin Endo, Yasuhiro Takikawa, et al.
BMJ Open Gastroenterology|March 13, 2018
Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trialKazunori Yoh, Hiroki Nishikawa, Hirayuki Enomoto, et al.
BMJ Open Gastroenterology|January 16, 2018
Clinical influence of exercise therapy on sarcopenia in patients with chronic pancreatitis: a study protocol for a randomised controlled trialKazunori Yoh, Hiroki Nishikawa, Hirayuki Enomoto, et al.
Gastroenterology Research and Practice|April 11, 2015
A new metabolism-related index correlates with the degree of liver fibrosis in hepatitis C virus-positive patientsHirayuki Enomoto, Nobuhiro Aizawa, Hideji Nakamura, et al.
Journal of Gastroenterology|April 1, 2021
Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitisJun Itakura, Masayuki Kurosaki, Hiroko Setoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 25, 2010
[A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of UFT-E]Hirayuki Enomoto, Akio Ishii, Hiroyasu Imanishi, et al.
Pageof 31